Labcyte to Merge with Deerac Fluidics | GenomeWeb
NEW YORK (GenomeWeb News) – Labcyte and Allegro Technologies, which conducts business as Deerac Fluidics, have agreed to merge, the companies said Sunday.
 
Financial terms of the deal were not disclosed.
 
Labcyte offers a droplet ejection technology that is used in compound management, assays, arraying, particle manufacturing, imaging mass spectrometry, and live cell transfer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.